...to isolate and expand. Newcos including GentiBio Inc., Kyverna Therapeutics Inc. and Sonoma Biotherapeutics emerged...

...to the board of directors at Gilead Sciences Inc. (NASDAQ:GILD). Bluestone is the president and CEO of Sonoma Biotherapeutics...
...CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux Inc. Chiesi Farmaceutici S.p.A. Oyster Point Pharma Inc. Sonoma Biotherapeutics Cellular...

...and Abbott Laboratories (NYSE:ABT) that included leadership roles in immuno-oncology and immunology drug discovery. Karen Tkach Tuzman Sonoma Biotherapeutics Lyell...

...other Treg-focused newcos have launched this year. Sonoma Biotherapeutics...

...biopharmas and other key players. Two newcos have launched since the start of the year. Sonoma Biotherapeutics...

...Founded by a team of T cell biology pioneers including the Parker Institute’s Jeffrey Bluestone, Sonoma Biotherapeutics...
...and inflammatory conditions using technology gained through its 2018 acquisition of TxCell S.A. COMPANY PROFILE Sonoma Biotherapeutics...